May 2020 FDA Recall Drug by Triova Pharmaceuticals Llc
D-1284-2020 - Failed impurities/ degradation specifications

This Class II drug recall was voluntarily initiated by Triova Pharmaceuticals Llc on May 15, 2020 for the product Drug. The FDA reported the reason for recall as failed impurities/ degradation specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1284-2020

Reason for Recall
Failed impurities/ degradation specifications: Out of specification for organic impurities.
Initiated
05-15-2020
Reported
06-10-2020
Quantity
210 grams

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
TRIOVA PHARMACEUTICALS LLC
Estriol USP Micronized 5 G, Rx only, Triova 115 W 3rd Street Suite 720 Tulsa, OK 74103, NDC 71092-9977-02

Batch or Lot Expiration Information

Lot# :17010401181119190927, EXP 12/2020, 1701040118111919092725200122, EXP.12/2020